title: Ceftriaxone-induced hemolysis.
abstract: Immune hemolytic anemia is a rare adverse effect of ceftriaxone, a third-generation cephalosporin, which is a commonly used antibiotic. We describe a 60-years-old lady, a case of community-acquired pneumonia, who developed severe hemolysis after the first dose of ceftriaxone. Her hemoglobin dropped from 9.6 g /dl to 5.5 g /dl. However, she improved after discontinuation of the drug and blood transfusion. This report serves as a reminder to medical fraternity that life-threatening hemolysis can rarely follow administration of ceftriaxone.
authors.affiliation: Department of Internal Medicine, Armed Forces Medical College, Pune - 411 040, India.
authors.forename: Vivek S
authors.initials: VS
authors.lastname: Guleria
authors.forename: Nitin
authors.initials: N
authors.lastname: Sharma
authors.forename: Sagar
authors.initials: S
authors.lastname: Amitabh
authors.forename: Velu
authors.initials: V
authors.lastname: Nair
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001803:Blood Transfusion; D002443:Ceftriaxone / Q000009:adverse effects*; D005260:Female; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone
keywords: ADRs; ceftriaxone; hemolysis